OARK | SIXH | OARK / SIXH | |
Gain YTD | 3.051 | 1.351 | 226% |
Net Assets | 70M | 439M | 16% |
Total Expense Ratio | N/A | N/A | - |
Turnover | 60.00 | 160.00 | 38% |
Yield | 38.40 | 1.77 | 2,176% |
Fund Existence | 2 years | 5 years | - |
OARK | SIXH | |
---|---|---|
RSI ODDS (%) | N/A | 11 days ago86% |
Stochastic ODDS (%) | 11 days ago79% | 11 days ago54% |
Momentum ODDS (%) | 11 days ago87% | 11 days ago52% |
MACD ODDS (%) | N/A | 11 days ago87% |
TrendWeek ODDS (%) | 11 days ago87% | 11 days ago56% |
TrendMonth ODDS (%) | 11 days ago81% | 11 days ago61% |
Advances ODDS (%) | 13 days ago90% | 16 days ago83% |
Declines ODDS (%) | 11 days ago78% | 12 days ago59% |
BollingerBands ODDS (%) | N/A | N/A |
Aroon ODDS (%) | 11 days ago85% | 11 days ago59% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JEEIX | 14.84 | 0.08 | +0.54% |
JHancock Infrastructure I | |||
VYMSX | 20.12 | 0.08 | +0.40% |
Voya Mid Cap Research Enhanced Index I | |||
FNDMX | 11.40 | 0.04 | +0.35% |
Fidelity Series Sust Non-US Dev Mrkt Fd | |||
JEPIX | 14.54 | 0.04 | +0.28% |
JPMorgan Equity Premium Income I | |||
FBTAX | 26.09 | -0.13 | -0.50% |
Fidelity Advisor Biotechnology A |
A.I.dvisor tells us that SIXH and AAPL have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SIXH and AAPL's prices will move in lockstep.
Ticker / NAME | Correlation To SIXH | 1D Price Change % | ||
---|---|---|---|---|
SIXH | 100% | +0.45% | ||
AAPL - SIXH | 14% Poorly correlated | +0.75% | ||
AMZN - SIXH | 14% Poorly correlated | +2.39% | ||
VZ - SIXH | 13% Poorly correlated | +1.15% | ||
MDT - SIXH | 12% Poorly correlated | +1.06% | ||
INTU - SIXH | 12% Poorly correlated | -0.52% | ||
More |